Table 3

Mean score changes (95% CI) in the outcome measures over time*

Week 0Week 16Week 32
Control group (N=60)Mean (95% CI)Mean (95% CI)Mean (95% CI)F2,118 (p value)
ASES (score range; higher score=greater self-efficacy)
 ASES-Pain (5–50)25.3 (22.4 to 28.2)26.5 (23.9 to 29.2)27.5 (24.6 to 30.3)2.03 (0.135)†
 ASES-Other symptoms (6–60)34.2 (30.9 to 37.4)35.0 (31.4 to 38.6)35.3 (31.5 to 39.0)0.40 (0.673)†
AIMS2-SF (score range; zero=good health status)
 AIMS2: physical (0–10)3.1 (2.4 to 3.8)3.0 (2.4 to 3.6)3.0 (2.4 to 3.7)0.09 (0.917)
 AIMS2: symptoms (0–10)5.0 (4.2 to 5.8)4.6 (3.8 to 5.4)5.1 (4.2 to 6.0)2.34 (0.101)
 AIMS2: affect(0–10)3.7 (3.2 to 4.3)3.8 (3.3 to 4.2)4.1 (3.5 to 4.7)2.18 (0.117)
 AIMS2: social(0–10)5.5 (5.1 to 6.0)5.6 (5.1 to 6.0)5.7 (5.3 to 6.2)1.86 (0.160)
 AIMS2: work‡(0–10)2.0 (0.9 to 3.1)3.4 (1.9 to 4.8)2.4 (−0.01 to 4.8)3.84 (0.028)
PKQ (score range, higher score=higher level of knowledge)
 Total PKQ (0–12)8.6 (7.9 to 9.2)8.7 (8.1 to 9.3)9.1 (8.4 to 9.8)1.96 (0.146)
Intervention group (N=68)Mean (95% CI)Mean (95% CI)Mean (95% CI)F2,134 (p value)
ASES(score range; higher score=greater self-efficacy)
 ASES-Pain (5–50)23.4 (21.2 to 25.6)27.0 (24.6 to 29.4)30.7 (28.2 to 33.2)37.5 (<0.001)†
 ASES-Other symptoms (6–60)30.6 (27.8 to 33.4)34.5 (31.4 to 37.5)38.7 (35.7 to 41.7)37.2 (<0.001)†
AIMS2-SF (score range; zero=good health status)
 AIMS2: physical (0–10)3.1 (2.6 to 3.6)2.8 (2.3 to 3.3)2.8 (2.3 to 3.4)2.35 (0.099)
 AIMS2: symptoms (0–10)5.4 (4.8 to 6.1)4.7 (4.0 to 5.4)4.3 (3.7 to 5.0)11.8 (<0.001)
 AIMS2: affect (0–10)4.3 (3.8 to 4.8)4.1 (3.5 to 4.6)3.6 (3.1 to 4.1)12.0 (<0.001)
 AIMS2: social (0–10)5.6 (5.2 to 6.0)5.5 (5.0 to 6.0)5.7 (5.2 to 6.2)1.35 (0.263)
 AIMS2: work‡(0–10)2.3 (1.2 to 3.4)2.8 (1.6 to 3.9)2.8 (1.5 to 5.0)0.60 (0.552)
PKQ (score range, higher score=higher level of knowledge)
 Total PKQ (0–12)8.6 (8.0 to 9.1)9.0 (8.5 to 9.5)9.2 (8.7 to 9.8)5.22 (0.007)
  • *Analysis not adjusted for baseline values as examining changes over time including values at baseline.

  • †Bonferroni-adjusted p value=0.025 for significance at the α level.

  • ‡All missing data imputed except for AIMS2-SF: Work where scores are only available for the patients who were working, week 16 and week 32 control group N=26 and intervention group N=33.

  • ASES, Arthritis Self Efficacy Scale; PKQ, patient knowledge questionnaire.